33

DAFTAR PUSTAKA

ASCO/CAP HER2 Test Guidelines Recommendation 2013.

Bancroft JD dan Gamble M. 2008. Theory and Practice of Histological

Techniques: Immunohistochemical Techniques. United State: Churchill

Livingstone Elsevier p.433-53.

Boenisch T. 2001. Immunochemical Staining Methods. DAKO Corporation:

Carpinteria, California.

Brandtzaeg P. 1981. Effects on Fluorescence Staining of Immunoglobulins and

Epithelia Components in Ethanol-and Formaldehyde-fixed Paraffin-

embedded Tissues. Histochemical Laboratory, Institute of Pathology, The

National, Riksbospitalet. The journal of Hischemistry and Cytochemistry:

(OA 80-248).

Burry RW. 2010. Controls for Immunocytochemistry: An Update. Department of

Neuroscience, College of Medicine, The Ohio State University, Columbus,

Ohio. Journal of Histochemistry & Cytochemistry 59(1) 6–12.

http://jhc.sagepub.com

Dabbs DJ. 2013. Diagnostic Immunohistochemistry: Theranostic and Genomic

Applications: Techniques of Immunohistochemistry: Principles. Pitfalls,

and Standarization 4th Edition. United States of America: Elsevier

Saunders p.1-19.

Gown AM. 2008. ASCO-CAP HER2 testing guidelines and validation studies.

Connection: 51.

Gray MJ, Gallick GE. 2010. The role of oncogene activation in tumor

progression. Mechanisms of oncogene. USA:Springer.Pg 19-22.

Harlow E and Lane D. 1988. Antibodies: A Laboratory Manual. Cold Spring

Harbor Laboratory. New York: 1-2, 78-85.

Howard GC dan Kaser MR. 2014. Making and Using Antibodies 2nd Edition.

Prancis: CRC Press p.303-9

http://jurnal.stikeskusumahusada.ac.id/index.php/JK/article/view/70/118.

Hutami R. 2009. Pembentukan Antibodi Poliklonal Matriks 1 Virus Influenza A

H1N1. Departemen Biologi FMIPA UI.

Kumar V, Abbas A, Fausto N, Aster J. 2010. Robbins and Cotran Pathologic

Basic of Disease 8th Edition. Philadelphia: Saunders Elsevier.

Kumar V, Cotran RS, dan Collins T. 2005. Neoplasia in Robbins Pathologic

Basic of Disease 7th Edition. Philadelphia: WB Saunders. p.269-71.

Maryam R. 2007. Produksi Antibodi Monoklonal Menggunakan Konjugat

Fumonisin B1 – Ovalbumin Sebagai Antigen Untuk Deteksi Fumonisin

Secara Imunoasai. Institut Pertanian Bogor.

Masruro YA. 2016. Pengecatan Imunohistokimia HER2 Menggunakan Susu Skim

dan Normal Serum. Universitas Muhammadiyah Semarang.

Nussbaum, R.L., McInnes, R.R., Willard, H.F. 2001. Thompson and Thompson

Genetics in Medicine 6th ed., WB Saunders Company, Philadelphia.

Olayioye, M.A. 2001. Update on HER-2 as a target for cancer therapy:

intracellular signaling pathways of ErbB2/HER-2 and family members.

Breast Cancer Res 3 (6): 385–389.

repository.unimus.ac.id

34

Palangka CRAP. 2014. Preparasi Dan Uji Stabilitas 177

Lu-DOTA F(Ab’)2 –

Nimotuzumab Sebagai Kandidat Radiofarmaka Terapi Kanker. UIN

Syarif Hidayatullah Jakarta.

Park MHM, Ebel JJ, Zhao W, Zynger DC. 2014. ER and PR

immunohistochemistry and HER2 FISH versus oncotype DX: implication

for breast cancer treatment. The Breast Journal 20 (1): 37-45.

Payne SJL, Bowen RL, Jones JL& Wells CA. 2008. Predictive markers in breast

cancer-the present. Histopathology; 52: p82-90.

Post Harvest Technology Institute. 1999. ELISA workshop: Simple test for

monitoring mycotoxins and pesticides in produce. University of Sydney,

9-10.

Pusat Data dan Informasi Kementrian Kesehatan RI tahun 2015. Stop Kanker.

Putra A, Tjahjono, Winarto. 2011. Ekstrak Keladi Tikus (Typonium flagelliforme)

Fraksi Diklorometanolik dan Ekspresi Caspase-3 dan p21 cell-Line Kanker

Payudara MCF-7. Fakultas Kedokteran Universitas Diponegoro dan Ikatan

Dokter Indonesia Wilayah Jawa Tengah.

Rahayu YC dan Auerkari EI. 2004. Teknik Imunohistokimia Sebagai Pendeteksi

Antigen Spesifik Penyakit Infeksi. Fakultas Kedokteran Gigi Universitas

Indonesia. Jakarta: 11(2): 76-82.

Ramo-Vara JA, Kiupel M, Baszler T, Bliven L, Brodersen B, Chelack B, Czub S,

Piero FD, Dial S, Ehrhart EJ, Graham T, Manning L, Paulsen D, Valli VE,

West K. 2008. Suggested guidelines for immunohistochemical techniques

in veterinary diagnostic laboratories. J Vet Diagn Invest 20:393–413.

R&D Systems A Biotechne Brand 20014.

Rittenburg JH and Smith CJ. 1990. Fundamental of immunoassay, In

Development and Application of Immunoassay for Food Analysis. J.H.

Rittenburg (Ed.). Elsevier Applied Science. London and New York, 29-57.

Sarkar, U.K., B.K. Gupta & W.S. Lakra. 2010. Biodiversity, ecohydrology, threat

status and conservation priority of freshwater fishes of River Gomti, a

tributary of River Ganga (India). Environmentalist 30: 3-17.

Shi Y, Huang W, dan Tan Y. 2009. A novel proximity assay for the detection of

proteins and protein complexes: quantitation of HER1 and HER2 total

protein expression and homodimerization in formalin-fixed, paraffin-

embeded cell lines and breast cancer tissue. Diagn Mol Pathol 18(1): 11-

21.

Sloane John P. 2003. Biopsy pathology of the breast. Biopsy pathology series 24,

2nd

ed. New York: Arnold; p. 62-9.

Starr trek HRP detection kit biocare.

Taylor CR dan Cote RJ. 2006. Immunomicroscopy: A Diagnostic Tool for The

Surgical Pathologist 3rd Edition. Philadelphia: Elsevier.

Taylor CR dan Rudbeck L. 2013. Immunohistochemical Staining Methods.

Department of Pathology, University of Southern Calfornia; Past Council

Member and President, Association of Pathology Chairs.

Unitly A.J Akiles, Sahertian D. Elisabeth. Deteksi Kandungan Antioksidan

Superoksida Dismustase (SOD) pada Organ Ginjal Rattus norvegicus

dengan Pewarnaan Imunohistokimia. Universitas Patimura Ambon.

repository.unimus.ac.id

35

Utari K, Nursafitri E, Sari Al, Sari R, Winda AK, Harti AS. 2013. Kegunaan daun

sirsak (Annona muricata L) untuk membunuh sel kanker dan pengganti

kemoterapi. Jurnal Kesmadaska 4 (2).

Vlahopoulos, S.A., Logotheti, S., Mikas, D., Giarika, A., Gorgoulis, V.,

Zoumpourlis, V. 2008. "The role of ATF-2 in oncogenesis". BioEssays 30

(4): 314–27.

Widiarti, Boewono DT, Widyastuti U. 2009. Deteksi Antigen Virus Dengue pada

Progen Vektor Demam Berdarah dengan Metode Imunohistokimia. Balai

Besar Penelitian dan Pengembangan Vektor dan Reservoir Penyakit

Salatiga. Vol. 37, No. 3: 126-136.

Wollf AC, Hicks DG, Dowsett M, Bilous M, Paik S, Hanna W, et al. 2013.

Recommendationsfor Human Epidermal Growth Factor Receptor 2

Testing in Breast Cancer: American Society of Clinical Oncology/College

of American Pathologist Clinical Practice Guideline Update. American

Society of Clinical Oncology and College of American Pathologists.

Yamashita-Kashima Y, Shu S, Yorozu K, Hashizume K, Moriya Y, Fujimoto-

Ouchi K, et al. 2014. Importance of formalin fixing condition for HER2

testing in gastric cancer: immunohistochemical staining and fluoresence in

situ hybridization. Springer 17: 638-47.

Yildirim S, Dandin O, Durmus M, Karapinar U, Aslan M, Gokce M, et al. 2012.

C-erBb2 (HER2/neu) expression rate and its association with

clinicopathologic parameters in gastric cancer. UHOD International

Journal of Hematology and Oncology 22(3): 156-62.

Zola H. 1987. Monoclonal Antibodies: A manual of techniques. CRP Press, Inc.

Boca Raton, Florida: 23-87.

repository.unimus.ac.id